- Home
- GBIO vs OGI Comparison
GBIO vs OGI Comparison
Compare GBIO & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- OGI
- Stock Information
- Founded
- GBIO 2016
- OGI 2013
- Country
- GBIO United States
- OGI Canada
- Employees
- GBIO N/A
- OGI N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- GBIO Health Care
- OGI Health Care
- Exchange
- GBIO Nasdaq
- OGI Nasdaq
- Market Cap
- GBIO 64.8M
- OGI 200.6M
- IPO Year
- GBIO 2020
- OGI N/A
- Fundamental
- Price
- GBIO $0.88
- OGI $1.53
- Analyst Decision
- GBIO Strong Buy
- OGI
- Analyst Count
- GBIO 2
- OGI 0
- Target Price
- GBIO $6.50
- OGI N/A
- AVG Volume (30 Days)
- GBIO 581.0K
- OGI 820.8K
- Earning Date
- GBIO 03-05-2025
- OGI 02-11-2025
- Dividend Yield
- GBIO N/A
- OGI N/A
- EPS Growth
- GBIO N/A
- OGI N/A
- EPS
- GBIO N/A
- OGI N/A
- Revenue
- GBIO $18,582,000.00
- OGI $118,317,480.00
- Revenue This Year
- GBIO $212.74
- OGI $57.65
- Revenue Next Year
- GBIO N/A
- OGI $10.93
- P/E Ratio
- GBIO N/A
- OGI N/A
- Revenue Growth
- GBIO 514.08
- OGI 0.69
- 52 Week Low
- GBIO $0.75
- OGI $1.31
- 52 Week High
- GBIO $4.65
- OGI $2.91
- Technical
- Relative Strength Index (RSI)
- GBIO 28.66
- OGI 44.32
- Support Level
- GBIO $0.85
- OGI $1.56
- Resistance Level
- GBIO $1.01
- OGI $1.77
- Average True Range (ATR)
- GBIO 0.12
- OGI 0.08
- MACD
- GBIO 0.00
- OGI -0.00
- Stochastic Oscillator
- GBIO 7.50
- OGI 11.11
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.